دورية أكاديمية

Vulnerable plaques and patients: state-of-the-art

التفاصيل البيبلوغرافية
العنوان: Vulnerable plaques and patients: state-of-the-art
المؤلفون: Tomaniak, M, Katagiri, Y, Modolo, R, Silva, RD, Khamis, RY, Bourantas, CV, Torii, R, Wentzel, JJ, Gijsen, FJH, Van Soest, G, Stone, PH, West, NEJ, Maehara, A, Lerman, A, Van der Steen, AFW, Lüscher, TF, Virmani, R, Koenig, W, Stone, GW, Muller, JE, Wijns, W, Serruys, PW, Onuma, Y
المساهمون: British Heart Foundation
المصدر: 3004 ; 2997
بيانات النشر: European Society of Cardiology
سنة النشر: 2020
المجموعة: Imperial College London: Spiral
مصطلحات موضوعية: Thin-cap fibroatheroma, Acute coronary syndromes, Cardiovascular pharmacotherapy, Culprit plaque, New invasive coronary imaging modalities, Plaque erosion, Plaque rupture, Vulnerable plaque, 1102 Cardiorespiratory Medicine and Haematology, 1103 Clinical Sciences, Cardiovascular System & Hematology
جغرافية الموضوع: England
الوصف: Despite advanced understanding of the biology of atherosclerosis, coronary heart disease remains the leading cause of death worldwide. Progress has been challenging as half of the individuals who suffer sudden cardiac death do not experience premonitory symptoms. Furthermore, it is well-recognized that also a plaque that does not cause a haemodynamically significant stenosis can trigger a sudden cardiac event, yet the majority of ruptured or eroded plaques remain clinically silent. In the past 30 years since the term 'vulnerable plaque' was introduced, there have been major advances in the understanding of plaque pathogenesis and pathophysiology, shifting from pursuing features of 'vulnerability' of a specific lesion to the more comprehensive goal of identifying patient 'cardiovascular vulnerability'. It has been also recognized that aside a thin-capped, lipid-rich plaque associated with plaque rupture, acute coronary syndromes (ACS) are also caused by plaque erosion underlying between 25% and 60% of ACS nowadays, by calcified nodule or by functional coronary alterations. While there have been advances in preventive strategies and in pharmacotherapy, with improved agents to reduce cholesterol, thrombosis, and inflammation, events continue to occur in patients receiving optimal medical treatment. Although at present the positive predictive value of imaging precursors of the culprit plaques remains too low for clinical relevance, improving coronary plaque imaging may be instrumental in guiding pharmacotherapy intensity and could facilitate optimal allocation of novel, more aggressive, and costly treatment strategies. Recent technical and diagnostic advances justify continuation of interdisciplinary research efforts to improve cardiovascular prognosis by both systemic and 'local' diagnostics and therapies. The present state-of-the-art document aims to present and critically appraise the latest evidence, developments, and future perspectives in detection, prevention, and treatment of 'high-risk' plaques occurring in ...
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 0195-668X
العلاقة: European Heart Journal; http://hdl.handle.net/10044/1/81094Test; FS/17/16/32560
DOI: 10.1093/eurheartj/ehaa227
الإتاحة: https://doi.org/10.1093/eurheartj/ehaa227Test
http://hdl.handle.net/10044/1/81094Test
حقوق: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com. This is a pre-copy-editing, author-produced version of an article accepted for publication in European Heart Journal following peer review. The definitive publisher-authenticated version is available online at: https://doi.org/10.1093/eurheartj/ehaa227Test ; 2021-05-13
رقم الانضمام: edsbas.47F31582
قاعدة البيانات: BASE
ResultId 1
Header edsbas
BASE
edsbas.47F31582
848
3
Academic Journal
academicJournal
847.616333007813
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.47F31582&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Array ( [0] => Array ( [Url] => https://doi.org/10.1093/eurheartj/ehaa227# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) [1] => Array ( [Url] => https://resolver.ebscohost.com/openurl?custid=s6537998&groupid=main&authtype=ip,guest&sid=EBSCO:edsbas&genre=article&issn=0195668X&ISBN=&volume=&issue=&date=20200101&spage=&pages=&title=3004 ; 2997&atitle=Vulnerable%20plaques%20and%20patients%3A%20state-of-the-art&id=DOI:10.1093/eurheartj/ehaa227 [Name] => Full Text Finder (s6537998api) [Category] => fullText [Text] => Full Text Finder [Icon] => https://imageserver.ebscohost.com/branding/images/FTF.gif [MouseOverText] => Full Text Finder ) )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Vulnerable plaques and patients: state-of-the-art )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Tomaniak%2C+M%22">Tomaniak, M</searchLink><br /><searchLink fieldCode="AR" term="%22Katagiri%2C+Y%22">Katagiri, Y</searchLink><br /><searchLink fieldCode="AR" term="%22Modolo%2C+R%22">Modolo, R</searchLink><br /><searchLink fieldCode="AR" term="%22Silva%2C+RD%22">Silva, RD</searchLink><br /><searchLink fieldCode="AR" term="%22Khamis%2C+RY%22">Khamis, RY</searchLink><br /><searchLink fieldCode="AR" term="%22Bourantas%2C+CV%22">Bourantas, CV</searchLink><br /><searchLink fieldCode="AR" term="%22Torii%2C+R%22">Torii, R</searchLink><br /><searchLink fieldCode="AR" term="%22Wentzel%2C+JJ%22">Wentzel, JJ</searchLink><br /><searchLink fieldCode="AR" term="%22Gijsen%2C+FJH%22">Gijsen, FJH</searchLink><br /><searchLink fieldCode="AR" term="%22Van+Soest%2C+G%22">Van Soest, G</searchLink><br /><searchLink fieldCode="AR" term="%22Stone%2C+PH%22">Stone, PH</searchLink><br /><searchLink fieldCode="AR" term="%22West%2C+NEJ%22">West, NEJ</searchLink><br /><searchLink fieldCode="AR" term="%22Maehara%2C+A%22">Maehara, A</searchLink><br /><searchLink fieldCode="AR" term="%22Lerman%2C+A%22">Lerman, A</searchLink><br /><searchLink fieldCode="AR" term="%22Van+der+Steen%2C+AFW%22">Van der Steen, AFW</searchLink><br /><searchLink fieldCode="AR" term="%22Lüscher%2C+TF%22">Lüscher, TF</searchLink><br /><searchLink fieldCode="AR" term="%22Virmani%2C+R%22">Virmani, R</searchLink><br /><searchLink fieldCode="AR" term="%22Koenig%2C+W%22">Koenig, W</searchLink><br /><searchLink fieldCode="AR" term="%22Stone%2C+GW%22">Stone, GW</searchLink><br /><searchLink fieldCode="AR" term="%22Muller%2C+JE%22">Muller, JE</searchLink><br /><searchLink fieldCode="AR" term="%22Wijns%2C+W%22">Wijns, W</searchLink><br /><searchLink fieldCode="AR" term="%22Serruys%2C+PW%22">Serruys, PW</searchLink><br /><searchLink fieldCode="AR" term="%22Onuma%2C+Y%22">Onuma, Y</searchLink> )
Array ( [Name] => Author [Label] => Contributors [Group] => Au [Data] => British Heart Foundation )
Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => 3004 ; 2997 )
Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => European Society of Cardiology )
Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2020 )
Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => Imperial College London: Spiral )
Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Thin-cap+fibroatheroma%22">Thin-cap fibroatheroma</searchLink><br /><searchLink fieldCode="DE" term="%22Acute+coronary+syndromes%22">Acute coronary syndromes</searchLink><br /><searchLink fieldCode="DE" term="%22Cardiovascular+pharmacotherapy%22">Cardiovascular pharmacotherapy</searchLink><br /><searchLink fieldCode="DE" term="%22Culprit+plaque%22">Culprit plaque</searchLink><br /><searchLink fieldCode="DE" term="%22New+invasive+coronary+imaging+modalities%22">New invasive coronary imaging modalities</searchLink><br /><searchLink fieldCode="DE" term="%22Plaque+erosion%22">Plaque erosion</searchLink><br /><searchLink fieldCode="DE" term="%22Plaque+rupture%22">Plaque rupture</searchLink><br /><searchLink fieldCode="DE" term="%22Vulnerable+plaque%22">Vulnerable plaque</searchLink><br /><searchLink fieldCode="DE" term="%221102+Cardiorespiratory+Medicine+and+Haematology%22">1102 Cardiorespiratory Medicine and Haematology</searchLink><br /><searchLink fieldCode="DE" term="%221103+Clinical+Sciences%22">1103 Clinical Sciences</searchLink><br /><searchLink fieldCode="DE" term="%22Cardiovascular+System+%26+Hematology%22">Cardiovascular System & Hematology</searchLink> )
Array ( [Name] => Subject [Label] => Subject Geographic [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22England%22">England</searchLink> )
Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Despite advanced understanding of the biology of atherosclerosis, coronary heart disease remains the leading cause of death worldwide. Progress has been challenging as half of the individuals who suffer sudden cardiac death do not experience premonitory symptoms. Furthermore, it is well-recognized that also a plaque that does not cause a haemodynamically significant stenosis can trigger a sudden cardiac event, yet the majority of ruptured or eroded plaques remain clinically silent. In the past 30 years since the term 'vulnerable plaque' was introduced, there have been major advances in the understanding of plaque pathogenesis and pathophysiology, shifting from pursuing features of 'vulnerability' of a specific lesion to the more comprehensive goal of identifying patient 'cardiovascular vulnerability'. It has been also recognized that aside a thin-capped, lipid-rich plaque associated with plaque rupture, acute coronary syndromes (ACS) are also caused by plaque erosion underlying between 25% and 60% of ACS nowadays, by calcified nodule or by functional coronary alterations. While there have been advances in preventive strategies and in pharmacotherapy, with improved agents to reduce cholesterol, thrombosis, and inflammation, events continue to occur in patients receiving optimal medical treatment. Although at present the positive predictive value of imaging precursors of the culprit plaques remains too low for clinical relevance, improving coronary plaque imaging may be instrumental in guiding pharmacotherapy intensity and could facilitate optimal allocation of novel, more aggressive, and costly treatment strategies. Recent technical and diagnostic advances justify continuation of interdisciplinary research efforts to improve cardiovascular prognosis by both systemic and 'local' diagnostics and therapies. The present state-of-the-art document aims to present and critically appraise the latest evidence, developments, and future perspectives in detection, prevention, and treatment of 'high-risk' plaques occurring in ... )
Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper )
Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English )
Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 0195-668X )
Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => European Heart Journal; http://hdl.handle.net/10044/1/81094; FS/17/16/32560 )
Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1093/eurheartj/ehaa227 )
Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://doi.org/10.1093/eurheartj/ehaa227<br />http://hdl.handle.net/10044/1/81094 )
Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com. This is a pre-copy-editing, author-produced version of an article accepted for publication in European Heart Journal following peer review. The definitive publisher-authenticated version is available online at: https://doi.org/10.1093/eurheartj/ehaa227 ; 2021-05-13 )
Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.47F31582 )
RecordInfo Array ( [BibEntity] => Array ( [Identifiers] => Array ( [0] => Array ( [Type] => doi [Value] => 10.1093/eurheartj/ehaa227 ) ) [Languages] => Array ( [0] => Array ( [Text] => English ) ) [Subjects] => Array ( [0] => Array ( [SubjectFull] => England [Type] => general ) [1] => Array ( [SubjectFull] => Thin-cap fibroatheroma [Type] => general ) [2] => Array ( [SubjectFull] => Acute coronary syndromes [Type] => general ) [3] => Array ( [SubjectFull] => Cardiovascular pharmacotherapy [Type] => general ) [4] => Array ( [SubjectFull] => Culprit plaque [Type] => general ) [5] => Array ( [SubjectFull] => New invasive coronary imaging modalities [Type] => general ) [6] => Array ( [SubjectFull] => Plaque erosion [Type] => general ) [7] => Array ( [SubjectFull] => Plaque rupture [Type] => general ) [8] => Array ( [SubjectFull] => Vulnerable plaque [Type] => general ) [9] => Array ( [SubjectFull] => 1102 Cardiorespiratory Medicine and Haematology [Type] => general ) [10] => Array ( [SubjectFull] => 1103 Clinical Sciences [Type] => general ) [11] => Array ( [SubjectFull] => Cardiovascular System & Hematology [Type] => general ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Vulnerable plaques and patients: state-of-the-art [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Tomaniak, M ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Katagiri, Y ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Modolo, R ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Silva, RD ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Khamis, RY ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Bourantas, CV ) ) ) [6] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Torii, R ) ) ) [7] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Wentzel, JJ ) ) ) [8] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Gijsen, FJH ) ) ) [9] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Van Soest, G ) ) ) [10] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Stone, PH ) ) ) [11] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => West, NEJ ) ) ) [12] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Maehara, A ) ) ) [13] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Lerman, A ) ) ) [14] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Van der Steen, AFW ) ) ) [15] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Lüscher, TF ) ) ) [16] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Virmani, R ) ) ) [17] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Koenig, W ) ) ) [18] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Stone, GW ) ) ) [19] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Muller, JE ) ) ) [20] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Wijns, W ) ) ) [21] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Serruys, PW ) ) ) [22] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Onuma, Y ) ) ) [23] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => British Heart Foundation ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 01 [Type] => published [Y] => 2020 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-print [Value] => 0195668X ) [1] => Array ( [Type] => issn-locals [Value] => edsbas ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => 3004 ; 2997 [Type] => main ) ) ) ) ) ) )
IllustrationInfo